Poorer cognitive performance in humans with mild cognitive impairment carrying the T variant of the Glu/Asp NOS3 polymorphism

Neuroscience Letters

Volumn 358, Issue 1, 2004, Pages 5-8

  Solé Padullés, Cristina ^a   Bartrés Faz, David ^a,b   Junqué, Carme ^a,b   Via, Marc ^a   Matarín, Mar ^a   González Pérez, Emili ^a   Moral, Pedro ^a   Moya, Antoni ^c   Clemente, Immaculada C ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INST D INVESTIGACIONS B   (Spain)

^c CAP Castellar del Valles   (Spain)

Author keywords

Alzheimer's disease; Frontal lobe function; Memory; Mild cognitive impairment (MCI); Nitric oxide synthase 3 (NOS3)

Indexed keywords

ASPARTIC ACID; GLUTAMIC ACID;

ADULT; AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEALTH STATUS; HUMAN; INTELLIGENCE TEST; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PHONETICS; PRIORITY JOURNAL; RATING SCALE; SAMPLING; TASK PERFORMANCE; VERBAL BEHAVIOR; VISUAL MEMORY;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ASPARTIC ACID; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; FEMALE; GENOTYPE; GLUTAMIC ACID; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; ODDS RATIO; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 1542285365     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.12.044     Document Type: Article

References (20)

1. Bartres-Faz D., Junque C., Lopez-Alomar A., Valveny N., Moral P., Casamayor R., Salido A., Bel C., Clemente I.C. Neuropsychological and genetic differences between age-associated memory impairment and mild cognitive impairment entities. J. Am. Geriatr. Soc. 49:2001;985-990.
2. Bartres-Faz D., Junque C., Lopez A., Valveny N., Moral P., Galvez E., Lopez T., Moya A., Navarro J.L., Clemente I. Apo E influences declarative and procedural learning in age-associated memory impairment. NeuroReport. 10:1999;2923-2927.
3. Bryan J., Luszcz M.A., Crawford J.R. Verbal knowledge and speed of information processing as mediators of age differences in verbal fluency performance among older adults. Psychol. Aging. 12:1997;473-478.
4. Crawford F., Freeman M., Abdullah L., Schinka J., Gold M., Duara R., Mullan M. No association between the NOS3 codon 298 polymorphism and Alzheimer's disease in a sample from the United States. Ann. Neurol. 47:2000;687.
5. Dahiyat M., Cumming A., Harrington C., Wischik C., Xuereb J., Corrigan F., Breen G., Shaw D., St. Clair D. Association between Alzheimer's disease and the NOS3 gene. Ann. Neurol. 46:1999;664-667.
6. de la Torre J.C., Stefano G.B. Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res. Brain Res. Rev. 34:2000;119-136.
7. Frisoni G.B., Galluzzi S., Bresciani L., Zanetti O., Geroldi C. Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome. J. Neurol. 249:2002;1423-1432.
8. Hachinski V., Muñoz D. Vascular factors in cognitive impairment - where are we now? Ann. N. Y. Acad. Sci. 903:2000;1-5.
9. Hänninen T., Hallikainen M., Koivisto K., Helkala E.L., Reinikainen K.J., Soininen H., Mykkanen L., Laakso M., Pyorala K., Riekkinen P.J. Sr. A follow-up study of age-associated memory impairment: neuropsychological predictors of dementia. J. Am. Geriatr. Soc. 43:1995;1007-1015.
10. Higuchi S., Ohta S., Matsushita S., Matsui T., Yuzuriha T., Urakami K., Arai H. NOS3 polymorphism not associated with Alzheimer's disease in Japanese. Ann. Neurol. 48:2000;685.
11. Jellinger K.A. Alzheimer disease and cerebrovascular pathology: an update. J. Neural Transm. 109:2002;813-836.
12. Kunugi H., Akahane A., Ueki A., Otsuka M., Isse K., Hirasawa H., Kato N., Nabika T., Kobayashi S., Nanko S. No evidence for an association between the Glu298Asp polymorphism of the NOS3 gene and Alzheimer's disease. J. Neural Transm. 107:2000;1081-1084.
13. Lembo G., De Luca N., Battagli C., Iovino G., Aretini A., Musicco M., Frati G., Pompeo F., Vecchione C., Trimarco B. A common variant of endothelial nitric oxide synthase [Glu298Asp] is an independent risk factor for carotid atherosclerosis. Stroke. 32:2001;735-740.
14. Looi J.C., Sachdev P.S. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology. 53:1999;670-678.
15. Monastero R., Cefalu A.B., Camarda C., Buglino C.M., Mannino M., Barbagallo C.M., Lopez G., Camarda L.K., Travali S., Camarda R., Averna M.R. No association between Glu298Asp endothelial nitric oxide synthase polymorphism and Italian sporadic Alzheimer's disease. Neurosci. Lett. 341:2003;229-232.
16. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Kokmen E., Tangelos E.G. Aging, memory, and mild cognitive impairment. Int. Psychogeriatr. 9:1997;65-69.
17. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56:1999;303-308.
18. Philip I., Plantefeve G., Vuillaumier-Barrot S., Vicaut E., LeMarie C., Henrion D., Poirier O., Levy B.I., Desmonts J.M., Durand G., Benessiano J. G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation. 99:1999;3096-3098.
19. Sanchez-Guerra M., Combarros O., Alvarez-Arcaya A., Mateo I., Berciano J., Gonzalez-Garcia J., Llorca J. The Glu298Asp polymorphism in the NOS3 gene is not associated with sporadic Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 70:2001;566-567.
20. Via M., Lopez-Alomar A., Valveny N., Gonzalez-Perez E., Bao M., Esteban E., Pinto X., Domingo E., Moral P. Lack of association between eNOS gene polymorphisms and ischemic heart disease in the Spanish population. Am. J. Med. Genet. 30:2003;243-248.